Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 5 | 2024 | 253 | 2.660 |
Why?
|
| Coronary Artery Disease | 6 | 2020 | 220 | 2.250 |
Why?
|
| Heart Transplantation | 6 | 2015 | 43 | 1.880 |
Why?
|
| Percutaneous Coronary Intervention | 5 | 2020 | 291 | 1.550 |
Why?
|
| Electrocardiography | 6 | 2024 | 398 | 1.360 |
Why?
|
| Stroke Volume | 4 | 2024 | 124 | 1.300 |
Why?
|
| Stents | 6 | 2014 | 121 | 1.240 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2020 | 26 | 1.030 |
Why?
|
| Coronary Angiography | 6 | 2015 | 150 | 0.930 |
Why?
|
| Exercise Tolerance | 3 | 2022 | 82 | 0.880 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 33 | 0.870 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2013 | 52 | 0.850 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2023 | 35 | 0.810 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 351 | 0.800 |
Why?
|
| Heart Rate | 1 | 2024 | 382 | 0.760 |
Why?
|
| Vascular Diseases | 2 | 2015 | 68 | 0.760 |
Why?
|
| Time Factors | 7 | 2020 | 1613 | 0.710 |
Why?
|
| Drug-Eluting Stents | 2 | 2013 | 102 | 0.690 |
Why?
|
| Aged | 16 | 2024 | 5598 | 0.680 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 64 | 0.660 |
Why?
|
| Humans | 30 | 2024 | 28851 | 0.640 |
Why?
|
| Walk Test | 1 | 2020 | 20 | 0.630 |
Why?
|
| Registries | 3 | 2015 | 396 | 0.600 |
Why?
|
| Walking | 2 | 2020 | 136 | 0.590 |
Why?
|
| Middle Aged | 14 | 2024 | 7414 | 0.580 |
Why?
|
| Peripartum Period | 1 | 2018 | 6 | 0.570 |
Why?
|
| Puerperal Disorders | 1 | 2018 | 14 | 0.560 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 16 | 0.560 |
Why?
|
| Male | 19 | 2024 | 13921 | 0.540 |
Why?
|
| Female | 17 | 2024 | 15624 | 0.530 |
Why?
|
| Treatment Outcome | 9 | 2020 | 2426 | 0.520 |
Why?
|
| Atrial Fibrillation | 5 | 2020 | 404 | 0.520 |
Why?
|
| Recovery of Function | 3 | 2024 | 123 | 0.490 |
Why?
|
| Coronary Vessels | 2 | 2016 | 154 | 0.490 |
Why?
|
| Coronary Restenosis | 2 | 2013 | 21 | 0.490 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 5 | 0.480 |
Why?
|
| Allografts | 1 | 2015 | 11 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 245 | 0.460 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2014 | 4 | 0.450 |
Why?
|
| Vascular Malformations | 1 | 2014 | 5 | 0.450 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 11 | 0.450 |
Why?
|
| Guideline Adherence | 1 | 2015 | 95 | 0.450 |
Why?
|
| Mammary Arteries | 1 | 2014 | 6 | 0.450 |
Why?
|
| Subclavian Artery | 1 | 2014 | 14 | 0.450 |
Why?
|
| Risk Factors | 8 | 2018 | 2126 | 0.450 |
Why?
|
| Vascular System Injuries | 1 | 2014 | 19 | 0.440 |
Why?
|
| Patient Admission | 1 | 2014 | 30 | 0.430 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 55 | 0.430 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 77 | 0.400 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 47 | 0.390 |
Why?
|
| United States | 5 | 2020 | 2222 | 0.390 |
Why?
|
| Sirolimus | 1 | 2013 | 76 | 0.390 |
Why?
|
| Heart | 2 | 2024 | 232 | 0.380 |
Why?
|
| Veterans | 1 | 2013 | 69 | 0.370 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2011 | 24 | 0.350 |
Why?
|
| Renal Artery Obstruction | 1 | 2011 | 4 | 0.350 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 7 | 0.350 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 13 | 0.340 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2011 | 21 | 0.340 |
Why?
|
| Pelvis | 1 | 2011 | 38 | 0.340 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 21 | 0.340 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 41 | 0.340 |
Why?
|
| Metals | 1 | 2011 | 41 | 0.340 |
Why?
|
| Postoperative Complications | 1 | 2015 | 634 | 0.340 |
Why?
|
| Coronary Thrombosis | 1 | 2011 | 36 | 0.330 |
Why?
|
| Heparin | 1 | 2011 | 111 | 0.330 |
Why?
|
| Atrial Flutter | 1 | 2010 | 13 | 0.330 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 98 | 0.330 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 74 | 0.330 |
Why?
|
| Prospective Studies | 5 | 2020 | 1280 | 0.320 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 113 | 0.310 |
Why?
|
| Retrospective Studies | 5 | 2015 | 2635 | 0.310 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 336 | 0.300 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 115 | 0.290 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 1032 | 0.260 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 271 | 0.260 |
Why?
|
| Peripheral Arterial Disease | 2 | 2022 | 144 | 0.240 |
Why?
|
| Risk Assessment | 3 | 2020 | 631 | 0.240 |
Why?
|
| Respiratory Rate | 1 | 2024 | 8 | 0.220 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 485 | 0.200 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.200 |
Why?
|
| Young Adult | 3 | 2018 | 2833 | 0.200 |
Why?
|
| Adult | 5 | 2019 | 8024 | 0.190 |
Why?
|
| Heart Ventricles | 1 | 2023 | 139 | 0.190 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 114 | 0.190 |
Why?
|
| White Matter | 1 | 2023 | 90 | 0.190 |
Why?
|
| Acute Disease | 3 | 2011 | 155 | 0.190 |
Why?
|
| Prosthesis Design | 2 | 2013 | 88 | 0.180 |
Why?
|
| Neoplasms | 1 | 2011 | 874 | 0.180 |
Why?
|
| Exercise Therapy | 1 | 2022 | 84 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 2065 | 0.170 |
Why?
|
| Survival Rate | 2 | 2013 | 432 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 191 | 0.170 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 138 | 0.170 |
Why?
|
| Hypertension | 1 | 2023 | 309 | 0.160 |
Why?
|
| Neurovascular Coupling | 1 | 2022 | 154 | 0.160 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 25 | 0.160 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 41 | 0.150 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 64 | 0.150 |
Why?
|
| Quality of Life | 1 | 2022 | 521 | 0.140 |
Why?
|
| Echocardiography | 1 | 2018 | 110 | 0.140 |
Why?
|
| Anticoagulants | 2 | 2011 | 297 | 0.130 |
Why?
|
| Angina Pectoris, Variant | 1 | 2016 | 3 | 0.120 |
Why?
|
| Coronary Vasospasm | 1 | 2016 | 4 | 0.120 |
Why?
|
| Prognosis | 2 | 2015 | 811 | 0.120 |
Why?
|
| Vasoconstriction | 1 | 2016 | 45 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 79 | 0.120 |
Why?
|
| Long Term Adverse Effects | 1 | 2015 | 2 | 0.120 |
Why?
|
| Aging | 2 | 2022 | 1016 | 0.110 |
Why?
|
| Angioplasty | 1 | 2014 | 12 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 159 | 0.110 |
Why?
|
| Holidays | 1 | 2014 | 4 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 261 | 0.110 |
Why?
|
| American Heart Association | 1 | 2014 | 21 | 0.110 |
Why?
|
| Angiography | 2 | 2011 | 35 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 203 | 0.110 |
Why?
|
| Pregnancy | 1 | 2018 | 1254 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 48 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2013 | 46 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2019 | 897 | 0.100 |
Why?
|
| Aspirin | 1 | 2014 | 125 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 268 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2013 | 190 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2014 | 120 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1507 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 254 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 120 | 0.100 |
Why?
|
| Intermittent Claudication | 1 | 2014 | 117 | 0.100 |
Why?
|
| Brugada Syndrome | 1 | 2012 | 4 | 0.100 |
Why?
|
| Fever | 1 | 2012 | 31 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 150 | 0.090 |
Why?
|
| Aortic Rupture | 1 | 2011 | 8 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2012 | 64 | 0.090 |
Why?
|
| Dogs | 2 | 2009 | 510 | 0.090 |
Why?
|
| Acetylcholine | 2 | 2009 | 73 | 0.090 |
Why?
|
| Anuria | 1 | 2011 | 2 | 0.090 |
Why?
|
| Graft Survival | 1 | 2011 | 29 | 0.090 |
Why?
|
| Saphenous Vein | 1 | 2011 | 24 | 0.090 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 48 | 0.090 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 20 | 0.090 |
Why?
|
| Vascular Grafting | 1 | 2011 | 11 | 0.090 |
Why?
|
| Catheters | 1 | 2011 | 24 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2011 | 44 | 0.080 |
Why?
|
| Palliative Care | 1 | 2011 | 86 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2011 | 274 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 146 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 524 | 0.080 |
Why?
|
| Atrial Appendage | 1 | 2009 | 32 | 0.070 |
Why?
|
| Incidence | 1 | 2010 | 572 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 26 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 108 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 787 | 0.070 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 47 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2009 | 223 | 0.060 |
Why?
|
| Heart Atria | 1 | 2008 | 177 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2008 | 270 | 0.060 |
Why?
|
| Adolescent | 1 | 2010 | 3193 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 93 | 0.050 |
Why?
|
| Arterioles | 1 | 2022 | 61 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 224 | 0.040 |
Why?
|
| Ear, External | 1 | 2020 | 13 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2020 | 106 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 379 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 422 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 841 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 467 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 737 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2016 | 1 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 334 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 41 | 0.030 |
Why?
|
| Nitrates | 1 | 2016 | 51 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 24 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2014 | 15 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2014 | 34 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 44 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 189 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 10684 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 249 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 465 | 0.020 |
Why?
|
| Pneumonia | 1 | 2012 | 89 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 995 | 0.020 |
Why?
|
| Oklahoma | 1 | 2014 | 1052 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 997 | 0.020 |
Why?
|
| Propafenone | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cholinergic Agents | 1 | 2009 | 6 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2009 | 17 | 0.020 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2008 | 2 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2009 | 117 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 43 | 0.020 |
Why?
|